The substance abuse and addiction treatment market has seen considerable growth due to a variety of factors.
• The market for treatment of addiction and substance abuse has seen swift growth in the past few years. The market size is set to expand from $11.74 billion in 2024 to $12.95 billion in 2025, experiencing a compound annual growth rate (CAGR) of 10.3%.
Factors such as heightening awareness, reduction of stigma, governmental strategies and financial backing, alterations in healthcare policies, advances in therapeutic methodologies, and the amalgamation of mental health with addiction treatment have contributed to the growth in the historic period.
The substance abuse and addiction treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The market for treatment of substance abuse and addiction is projected to witness significant expansion in the coming years, with its valuation poised to reach $19.54 billion by 2029. This represents a compound annual growth rate (CAGR) of 10.8%.
The anticipated growth during this period can be attributed to an escalating number of substance abuse cases, an emphasis on individualized treatment plans, wider availability of treatment services, innovations in telehealth and remote assistance, and advocacy for mental health. Key trends predicted for this period include the introduction of educational programs for prevention and awareness, partnerships with mental health professionals, remote support and interventions geared towards families, expansion of concierge outpatient treatment services, and the investigation into new therapeutic strategies.
The substance abuse and addiction treatment market is anticipated to grow due to the high prevalence of alcohol consumption. This refers to the intake of beverages containing ethyl alcohol. There has been an increased incidence of disorders resulting from alcohol usage, leading to a surge in demand for addiction treatment and substance abuse. For instance, the Office for Health Improvement and Disparities, an institution under the UK Department of Health and Social Care, reported in April 2024 that a total of 290,635 adults accessed drug and alcohol services between April 2022 and March 2023. This was a small increase from the previous year's total of 289,215. Furthermore, the adult population seeking treatment during this time was 137,749 - a significant increase from the prior two years, when the figures were 130,490 and 133,704 respectively. Consequently, the high occurrence of alcohol usage is contributing significantly to the expansion of the substance abuse and addiction treatment market.
The substance abuse and addiction treatment market covered in this report is segmented –
1) By Abuse Type: Alcohol Dependence, Tobacco Or Nicotine Addiction, Other Abuse Types
2) By Treatment: Alcohol Addiction Treatment, Tobacco Or Nicotine Addiction Treatment, Opioid Addiction Treatment, Other Treatments
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
Subsegments:
1) By Alcohol Dependence: Inpatient Treatment Programs, Outpatient Treatment Programs, Detoxification Services, Counseling And Therapy
2) By Tobacco Or Nicotine Addiction: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy, Support Groups
3) By Other Abuse Types: Opioid Addiction, Stimulant Addiction, Cannabis Dependence, Other Substance Abuse
To fortify their place in the substance abuse and addiction treatment market, key companies are creating innovative products such as nasal sprays. These nasal sprays like naloxone contain quick action medication that can instantly counteract life-endangering respiratory depression caused by opioid toxicity. For instance, Emergent BioSolutions, a biotechnology firm in the US, launched Narcan Naloxone HCL nasal spray in August 2023. This spray is designed for immediate treatment of opioid overdoses – swiftly counteracting the effects of opioids, including synthetic types like fentanyl. The formulation of the nasal spray permits easy and fast application without injections, thus being user-friendly for non-medically trained individuals in urgent scenarios. Taking into account the persistent opioid crisis, Narcan becomes significant as it capacitates individuals to react swiftly during an overdose, potentially rescuing lives till professional medical assistance arrives.
Major companies operating in the substance abuse and addiction treatment market include:
• Pfizer Inc.
• AbbVie Inc.
• Novartis AG
• Sanofi S.A.
• GlaxoSmithKline plc
• Allergan plc
• Teva Pharmaceutical Industries Ltd.
• Purdue Pharma LP
• Mallinckrodt Pharmaceuticals plc
• Cipla Limited
• The Priory Group
• Alkermes Inc.
• Promises Behavioral Health
• Indivior PLC
• American Addiction Centers Holdings Inc.
• Accord Healthcare Inc.
• Hazelden Betty Ford Foundation
• The Caron Foundation
• Noramco Inc.
• Recovery Centers of America
• Elements Behavioral Health LLC
• Cirque Lodge
• Foundations Recovery Network
• The Kusnacht Practice
• Ocean Breeze Recovery
• Behavioral Health Group Inc.
• BioCorRx Inc.
• MAP Health Management
• Seabrook
• Phoenix House
North America was the largest region in the substance abuse and addiction market in 2024. The regions covered in the substance abuse and addiction treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.